Gts Securities LLC Kronos Bio, Inc. Transaction History
Gts Securities LLC
- $2.31 Trillion
- Q1 2025
A detailed history of Gts Securities LLC transactions in Kronos Bio, Inc. stock. As of the latest transaction made, Gts Securities LLC holds 30,000 shares of KRON stock, worth $21,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,000
Previous 50,000
40.0%
Holding current value
$21,000
Previous $47.5 Million
47.89%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding KRON
# of Institutions
49Shares Held
19.4MCall Options Held
51.2KPut Options Held
0-
Vida Ventures Advisors, LLC2.77MShares$1.94 Million44.86% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.92MShares$1.35 Million0.0% of portfolio
-
Partners Capital Investment Group, LLP Boston, MA1.45MShares$1.01 Million0.02% of portfolio
-
Alphabet Inc. Mountain View, CA1.44MShares$1.01 Million0.11% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.43MShares$997,5450.0% of portfolio
About Kronos Bio, Inc.
- Ticker KRON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,769,100
- Market Cap $39.7M
- Description
- Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...